Acorda Therapeutics Inc

NASDAQ ACORQ

Data sourced from iex and EODHD
Download Data

Acorda Therapeutics Inc Income Statement 2023 - 2024

This table shows the Income Statement for Acorda Therapeutics Inc going from 2023 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Revenue
M 20 38 28 30 22
Cost of Revenue
M 4 6 3 3 3
Gross Profit
M 17 32 24 27 19
Operating Expenses
M 30 31 32 31 32
Selling, General, and Administrative Expenses (SG&A)
M 28 22 23 22 23
Research and Development (R&D) Expenses
M 1 1 1 2 1
Other Operating Expenses
M 1 8 8 8 8
Costs and Expenses
M 30 31 32 31 32
Operating Income
M -13 1 -8 -4 -13
Interest Expense
M 8 9 8 8 8
Non-operating Income/Expense
M -6 -249 6 1 1
EBT
M -27 -256 -10 -11 -19
Income Tax Provision
M - - - - -
Income after Tax
M - - - - -
Non-Controlling Interest
M - - - - -
Net Income
M - - - - -
Shares (Basic, Weighted)
M - - - - -
Shares (Diluted, Weighted)
R 1,242,098.00 1,242,098.00 1,242,098.00 1,242,098.00 1,216,889.00
EBITDA
M - - - - -
Depreciation and Amortization
M - - - - -
EBIT
M - - - - -
Income from Discontinued Operations
M - - - - -
Tax Rate (Effective)
% - - - - -
Earnings Per Share (EPS), Basic
M - - - - -
Earnings Per Share (EPS), Diluted
M - - - - -
Gross Profit Margin
% 81.73 85.26 87.78 89.67 85.47
Operating Income Margin
% -65.98 3.90 -27.86 -15.02 -56.46
Net Income Margin
% - - - - -
EBITDA Ratio
% - - - - -
EBIT Ratio
% - - - - -
EBT Ratio
% -134.46 -673.61 -35.88 -38.23 -84.74

StockViz Staff

September 16, 2024

Any question? Send us an email